Zelira Therapeutics Ltd. has released a press release.
Suspension from Official Quotation - Annual Listing Fees
Earlier from Zelira Therapeutics
- Long Term Suspended Entities
- Suspension from Quotation
- Quarterly Activities/Appendix 4C Cash Flow Report
- Transformative US$33M Fundraising into Zeliras HOPE 1 SPV